# Mechanisms of Hypoglycemia Associated Autonomic Dysfunction, Q4-Atomoxetine

> **NCT00780650** · EARLY_PHASE1 · COMPLETED · sponsor: **University of Maryland, Baltimore** · enrollment: 56 (actual)

## Conditions studied

- Type 1 Diabetes

## Interventions

- **DRUG:** Atomoxetine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00780650
- **Lead sponsor:** University of Maryland, Baltimore
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-05
- **Primary completion:** 2018-08-21
- **Final completion:** 2018-08-21
- **Target enrollment:** 56 (ACTUAL)
- **Last updated:** 2019-09-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00780650

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00780650, "Mechanisms of Hypoglycemia Associated Autonomic Dysfunction, Q4-Atomoxetine". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00780650. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*